Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation-Reference-Cited by-同舟云学术

Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation

Published:2016-09 Issue: Volume:145 Page:100-106
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Tomita Hideharu^ORCID,Araki Takuya,Kadokami Toshiaki,Yamada Satoshi,Nakamura Ryo,Imamura Yoshihiro,Fukuyama Takaya,Nagano Daisuke,Hashimoto Tomoya,Uematsu Akiko,Hosokawa Kazuya,Yamamoto Koujirou,Ueda Shin-ichiro,Ando Shin-ichi

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. RE-LY Steering Committee and Investigators, Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009

2. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial;Liesenfeld;J. Thromb. Haemost.,2011

3. A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgery;Dansirikul;Thromb. Haemost.,2012

4. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate;Stangier;Clin. Pharmacokinet.,2008

5. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY trial (randomized evaluation of long-term anticoagulation therapy);Reilly;J. Am. Coll. Cardiol.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta‐analysis of dabigatran peak and trough concentration in adults;British Journal of Clinical Pharmacology;2022-06-16

2. SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population;Frontiers in Genetics;2022-05-13

3. Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation;Heart and Vessels;2021-10-25

4. Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases;Current Research in Pharmacology and Drug Discovery;2021

5. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants;Polish Archives of Internal Medicine;2020-03-03